Press releases
- Local budding biologists explore the past, present and future during GSK Science in the Summer™ in partnership with the Franklin Institute
- GSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32% CER; Total EPS 35.9p +67% AER, +66% CER and Adjusted EPS 32.8p +43% AER, +43% CER
- US Food and Drug Administration accepts New Drug Application for daprodustat
Tweets from GSK US
-
GSKUS @GSKUS
#LupusAwarenessMonth is a time to educate and empower the #lupus community. We are proud partners of @LupusOrg as we continue to raise awareness of this chronic disease. Together, our shared ambition can make a difference in millions of lives impacted by lupus.
about 9 hours ago -
GSKUS @GSKUS
#DYK that 60% of adults living with asthma in the U.S. have #uncontrolledasthma? Swipe to see what GSK leader, Court Horncastle, has to say about how uncontrolled asthma can impact a patient’s quality of life. #AsthmaAwarenessMonth
about 10 hours ago -
GSKUS @GSKUS
#DYK that with each #COPD exacerbation, there may be a permanent loss of lung function? That’s why GSK prioritizes patient identification and is committed to helping people with COPD breathe better. #ATS2022
about 1 day ago
